なぜ私たちはDioseve社に投資したのか
Dioseve社は、iPS細胞由来の卵巣サポート技術を活用し、既存のIVFプロセスの中で卵子成熟の生物学的メカニズムそのものを構築しています。これにより、患者の治療向上を図りながら、実際の臨床現場のワークフローにも適合し、これまでニーズはあるものの明確な解決策がなかった問題に応えようとしています。
Why We Invested in Dioseve
Reproductive biology has emerged as an important frontier in hard tech, with the potential to reshape infertility. Dioseve is building at that intersection, which is why we chose Dioseve as Pangaea’s first startup investment in Japan. We have been laying the groundwork to support more hard tech founders in the country, and Dioseve is the first example of that strategy in action.
Pangaea Ventures Joins $18.7M Series A Investment in ChEmpower: Revolutionizing Semiconductor Manufacturing
We're excited to announce our participation in the oversubscribed $18.7M Series A financing for ChEmpower, a company that's pioneering a revolutionary approach to semiconductor manufacturing.
Marsapet Launches First Dog Food Featuring FeedKind Pet Protein
Calysta and Marsapet have launched the first complete dog food featuring FeedKind Pet protein, a cultured protein fermented without using any arable land or animal ingredients.
ESS Global Fleet Achieves Operational Milestone Surpassing 2 GWh of Transacted Energy
ESS Tech, Inc. announced that the company’s global fleet of LDES solutions has transacted nearly 2.5 GWh of transacted energy
CarbonCure Reveals Groundbreaking Carbon Utilization Collaboration in Saudi Arabia with Abdin and Gulf Cryo
The multi-party collaboration will enable embodied carbon reductions at NEOM's large scale construction projects.
Why We Invested in Green Theme Technologies
Our decision to lead the Series C funding round for Green Theme Technologies' (GTT), a company making textile production more sustainable, underscores our commitment to breakthrough technologies that enable better, more sustainable outcomes for industry and the environment
Kanvas Bio Unveils Clinical Data on the Gut Microbiome’s Impact on Anti-Tumoral Immunity at SITC
Kanvas Biosciences, a full-stack spatial biology company, announced data from a clinical trial that produced results that de-risk the development of Kanvas Bio’s lead immuno-oncology drug.
Crane NXT Acquires Smart Packaging Assets of TruTag Technologies, Further Expanding Capabilities in Product Security and Authentication Technologies
Crane NXT, Co. (NYSE: CXT), a premier industrial technology company, today announced that it has completed the acquisition of the Smart Packaging assets of TruTag Technologies.
CarbonCure Achieves Milestone 500,000 Tons Of CO2 Savings
CarbonCure Technologies has saved more than 500,000 metric tons of carbon dioxide (CO2) to date across 7.5 million truckloads of CarbonCure concrete.
Vestaron Corporation Announces Strategic Collaboration with ADM for Production of Peptide-Based Crop Protection Products
Agreement supports production scale-up to meet global demand for new crop solutions